Advertisement

Topics

Companies Related to "Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients" [Most Relevant Company Matches] RSS

05:24 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients" found in our extensive corporate database of over 50,000 company records.

Showing "Validation Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus" Companies 1–25 of 4,200+

Relevant

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...


AngioDesign, Inc

AngioDesign, Inc. is a new biotech start-up company focussed on the design of improved, next-generation drugs for proven disease targets. True validation of therapeutic targets in the clinic is by far the most costly part of the drug discovery and development process. AngioDesign will short-circuit the process by applying structure-guided drug design to proven disease targets and developing 2nd-ge...

Total Validation Services

Total Validation Services was orginally formed to provide independent contract validation services in the biotechnology industry.Today,we have grown to provede a broad range of validation quality and project managment services.Our work experience spans all facets of the pharmaceutical,biotechnology,and medical device industries.We assist client companies from validation review of engineering plans...


Traxtal Inc.

Traxtal, headquartered in Toronto, Canada, is the world leader and proven pioneer in the innovation, development and manufacture of computer assisted soft tissue navigation technologies. Introduced in 2007, its PercuNav system is the only image-guided diagnostic and interventional system cleared by the U.S. Food and Drug Administration that supports all imaging modalities, and the only such system...

Endocyte, Inc.

Endocyte is a privately held biotechnology company with headquarters in the Purdue Research Park of West Lafayette, IN. Based on the applications of Endocyte’s advanced proprietary guided drug technology, the company is working to develop new drugs and diagnostic agents to treat many types of cancer and other serious diseases. The guided drug platform...

GeNO LLC

GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and ...

Siena Biotech S.p.A.

SIENABIOTECH is an innovative drug discovery company whose research efforts are focussed on diseases of the central nervous system, either neurodegenerative or proliferative, including rare diseases with the aim of discovering new therapeutic intervention.In order to support the drug discovery process from exploratory target identification to clinical studies, the Company applies the most advanced...

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

Deltagen, Inc.

Deltagen, Inc. is a leading provider of drug discovery tools to the biopharmaceutical industry. Deltagen offers access to its extensive inventory of knockout mouse lines and related phenotypic data, which enhance the efficiency of target validation and drug discovery. In addition, Deltagen offers target validation data in the areas of immunology and metabo...

ConfometRx

ConfometRx is pioneering a platform of structure-based drug development tools that facilitate target validation, lead identification, and lead optimization for G protein coupled receptor (GPCR) targets. This platform includes biochemical and biophysical technologies for defining drug binding sites; the production of pure, functional GPCRs for high-resolution structure determination by crystallogra...

twoXAR, Inc.

Founded in 2014 by two entrepreneurs named Andrew Radin, twoXAR is transforming how large biological datasets are harnessed to accelerate the identification and validation of new medicines. Based in Palo Alto, California, the twoXAR team includes experts in drug discovery, biomedical informatics, computational biology, data science, software development an...

Chemocept, Inc.

Chemocept is a service company offering the biotechnology industry discovery chemistry support capabilities for use in biomolecular target validation and small molecule drug discovery. We facilitate the discovery of small molecule modulators of target bioactivity by providing chemoinformatics and medicinal chemistry services at reasonable cost. Identified modulators can be used as chemical genet...

Guided Therapeutics, Inc.

Guided Therapeutics, Inc. (OTCBB: GTHP) is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to provide an objective result at the point of care thereby improving the management of cervical disease. Unlike Pap and HPV tests, the device does not require a painful tissue sample a...

Dimerix

Dimerix is a privately owned drug discovery company which focuses on fully validated drug targets and leverages existing knowledge on drug-like molecules. As a consequence, Dimerix leapfrogs the initial, low-value drug discovery steps. Using innovative technologies, these existing drugs or drug-like compounds are modified in a rationale way to enhance their properties and achieve higher efficacy. ...

Vernalis Research

Vernalis Research has significant expertise in fragment and structure-based drug discovery. This expertise is used in collaborations that include projects to generate lead and candidate molecules against molecular targets across all therapeutic areas as well as establishing drug discovery and initial validation of novel targets. In addition, the Company ha...

Q-RNA, Inc.

Q-RNA, Inc., was founded in 1996 by Abraham Grossman, Ph.D., a molecular biologist with both academic and industry experience. The early efforts of Q-RNA were focused on the development of RNA (ribonucleic acid) ligands and their interaction with proteins. Recent discoveries have put Q-RNA in the forefront of opening the secrets to a vast number of protein misfolding disorders representing major u...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...

Image Guided Surgery Associates

Image Guided Surgery Associates, PC (IGSA) is a private medical practice specializing in Interventional Radiology/Image Guided Surgery. Interventional Radiology (IR) procedures are a major advancement in medicine because they involve less risk than open surgery, with less pain and a shorter recovery time. IGSA was founded in 2002 by Robert L. Worthington-Kirsch, MD, FSCVIR in order to deliver the ...

Validation in Partnership Ltd

Formed in 1995, Validation in Partnership is a limited company specialising in the provision of validation and CGMP (Current Good Manufacturing Practice) compliance services to the life science industries supplying the European and/or American markets. As a completely independent organisation, we pride ourselves on the provision of an impartial, flexible, and pragmatic service with up-to-the-min...

REVA Medical, Inc.

REVA is dedicated to developing minimally invasive medical devices that leverage the Company's proprietary biomaterial and stent technologies to improve the treatment of disease. Guided by a management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA's initial focus is the development and eventual commercialization of...

Masy Systems, Inc.

With over 20 years in business, Masy Systems is a knowledgeable and reputable provider of validation services, calibration services, validation equipment rentals and related products for the pharmaceutical and biotech industries. Equipment calibrations and rentals include NIST traceable certificates. We also offer ultra-premium thermocouple wire and custom harnesses, relative humidity and carbon...

Asterand Bioscience, Inc.

Asterand Bioscience, Inc. is the leading global provider of high quality, well-characterized human tissue and human tissue-based research services to support drug discovery and development. Asterand provides human-based solutions to pharmaceutical and biotechnology companies to accelerate the identification and validation of drug targets and biomarkers and...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with ...

Automation & Validation Solutions

Our company was specifically formed to serve the constantly evolving engineering and validation needs for the pharmaceutical, biotechnology, medical device and diagnostic industries. Our success is driven by our people. We provide our clients project leadership as partners to efficiently meet their goals. Our experience has been gained over a large number of complex projects covering a broad rang...

Gyrasol Technologies

Gyrasol Technologies offers homogeneous assay kits and custom development services for target validation or high throughput screening of emerging drug discovery targets. The Gyrasol Sensor directly measures the activity of kinases, phosphatases, proteases, phosphodiesterases and other difficult, novel, and proprietary drug targets.


More From BioPortfolio on "Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks